Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

MD vs AMSF vs THC vs KNTK

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MD
Pediatrix Medical Group, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$1.90B
5Y Perf.+47.6%
AMSF
AMERISAFE, Inc.

Insurance - Specialty

Financial ServicesNASDAQ • US
Market Cap$569M
5Y Perf.-50.6%
THC
Tenet Healthcare Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$17.01B
5Y Perf.+792.1%
KNTK
Kinetik Holdings Inc.

Oil & Gas Midstream

EnergyNASDAQ • US
Market Cap$3.33B
5Y Perf.+602.3%

MD vs AMSF vs THC vs KNTK — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MD logoMD
AMSF logoAMSF
THC logoTHC
KNTK logoKNTK
IndustryMedical - Care FacilitiesInsurance - SpecialtyMedical - Care FacilitiesOil & Gas Midstream
Market Cap$1.90B$569M$17.01B$3.33B
Revenue (TTM)$1.93B$325M$21.45B$1.73B
Net Income (TTM)$174M$46M$1.70B$228M
Gross Margin25.5%47.6%42.8%24.8%
Operating Margin11.9%17.8%16.1%8.2%
Forward P/E10.3x14.4x10.9x42.4x
Total Debt$660M$491K$13.17B$3.87B
Cash & Equiv.$375M$62M$2.88B$4M

MD vs AMSF vs THC vs KNTKLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MD
AMSF
THC
KNTK
StockMay 20May 26Return
Pediatrix Medical G… (MD)100147.6+47.6%
AMERISAFE, Inc. (AMSF)10049.4-50.6%
Tenet Healthcare Co… (THC)100892.1+792.1%
Kinetik Holdings In… (KNTK)100702.3+602.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: MD vs AMSF vs THC vs KNTK

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MD leads in 3 of 7 categories, making it the strongest pick for valuation and capital efficiency and recent price momentum and sentiment. AMERISAFE, Inc. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. KNTK also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
MD
Pediatrix Medical Group, Inc.
The Value Play

MD carries the broadest edge in this set and is the clearest fit for value and momentum.

  • Lower P/E (10.3x vs 42.4x)
  • +59.8% vs AMSF's -29.2%
  • 8.1% ROA vs KNTK's 4.2%, ROIC 14.8% vs 1.9%
Best for: value and momentum
AMSF
AMERISAFE, Inc.
The Insurance Pick

AMSF is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.

  • Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
  • 14.3% margin vs THC's 7.9%
  • Beta 0.23 vs MD's 0.73, lower leverage
Best for: sleep-well-at-night
THC
Tenet Healthcare Corporation
The Long-Run Compounder

THC is the clearest fit if your priority is long-term compounding.

  • 5.2% 10Y total return vs AMSF's 31.8%
Best for: long-term compounding
KNTK
Kinetik Holdings Inc.
The Income Pick

KNTK is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 3 yrs, beta 0.60, yield 16.5%
  • Rev growth 19.0%, EPS growth 157.8%, 3Y rev CAGR 13.3%
  • Beta 0.60, yield 16.5%, current ratio 0.69x
  • 19.0% revenue growth vs MD's -4.9%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthKNTK logoKNTK19.0% revenue growth vs MD's -4.9%
ValueMD logoMDLower P/E (10.3x vs 42.4x)
Quality / MarginsAMSF logoAMSF14.3% margin vs THC's 7.9%
Stability / SafetyAMSF logoAMSFBeta 0.23 vs MD's 0.73, lower leverage
DividendsKNTK logoKNTK16.5% yield, 3-year raise streak, vs AMSF's 8.4%, (2 stocks pay no dividend)
Momentum (1Y)MD logoMD+59.8% vs AMSF's -29.2%
Efficiency (ROA)MD logoMD8.1% ROA vs KNTK's 4.2%, ROIC 14.8% vs 1.9%

MD vs AMSF vs THC vs KNTK — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MDPediatrix Medical Group, Inc.
FY 2025
Health Care, Patient Service
85.2%$1.6B
Hospitals Contracts
14.2%$271M
Product and Service, Other
0.6%$12M
AMSFAMERISAFE, Inc.

Segment breakdown not available.

THCTenet Healthcare Corporation
FY 2025
Ambulatory Care
50.2%$5.2B
Hospital Operations
49.8%$5.1B
KNTKKinetik Holdings Inc.
FY 2025
Natural Gas, NGLs and Condensate Sales
74.1%$1.3B
Gathering and Processing Services
25.2%$445M
Product and Service, Other
0.7%$12M

MD vs AMSF vs THC vs KNTK — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAMSFLAGGINGMD

Income & Cash Flow (Last 12 Months)

AMSF leads this category, winning 4 of 6 comparable metrics.

THC is the larger business by revenue, generating $21.5B annually — 66.1x AMSF's $325M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to THC's 7.9%. On growth, AMSF holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMD logoMDPediatrix Medical…AMSF logoAMSFAMERISAFE, Inc.THC logoTHCTenet Healthcare …KNTK logoKNTKKinetik Holdings …
RevenueTrailing 12 months$1.9B$325M$21.5B$1.7B
EBITDAEarnings before interest/tax$252M$58M$4.3B$534M
Net IncomeAfter-tax profit$174M$46M$1.7B$228M
Free Cash FlowCash after capex$238M$8M$3.3B$441M
Gross MarginGross profit ÷ Revenue+25.5%+47.6%+42.8%+24.8%
Operating MarginEBIT ÷ Revenue+11.9%+17.8%+16.1%+8.2%
Net MarginNet income ÷ Revenue+9.0%+14.3%+7.9%+13.2%
FCF MarginFCF ÷ Revenue+12.3%+2.5%+15.6%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year+3.9%+10.3%+2.8%-7.5%
EPS Growth (YoY)Latest quarter vs prior year+50.0%-8.5%+87.6%-2.4%
AMSF leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

THC leads this category, winning 3 of 6 comparable metrics.

At 11.8x trailing earnings, MD trades at a 36% valuation discount to KNTK's 18.4x P/E. On an enterprise value basis, THC's 6.3x EV/EBITDA is more attractive than KNTK's 13.1x.

MetricMD logoMDPediatrix Medical…AMSF logoAMSFAMERISAFE, Inc.THC logoTHCTenet Healthcare …KNTK logoKNTKKinetik Holdings …
Market CapShares × price$1.9B$569M$17.0B$3.3B
Enterprise ValueMkt cap + debt − cash$2.2B$508M$27.3B$7.2B
Trailing P/EPrice ÷ TTM EPS11.82x12.27x12.53x18.43x
Forward P/EPrice ÷ next-FY EPS est.10.26x14.42x10.94x42.44x
PEG RatioP/E ÷ EPS growth rate0.38x
EV / EBITDAEnterprise value multiple8.66x8.53x6.34x13.14x
Price / SalesMarket cap ÷ Revenue1.00x1.80x0.80x1.89x
Price / BookPrice ÷ Book value/share2.26x2.30x1.97x1.04x
Price / FCFMarket cap ÷ FCF7.54x63.83x6.72x44.78x
THC leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

AMSF leads this category, winning 6 of 9 comparable metrics.

KNTK delivers a 21.1% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $10 for AMSF. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to THC's 1.47x. On the Piotroski fundamental quality scale (0–9), MD scores 7/9 vs KNTK's 4/9, reflecting strong financial health.

MetricMD logoMDPediatrix Medical…AMSF logoAMSFAMERISAFE, Inc.THC logoTHCTenet Healthcare …KNTK logoKNTKKinetik Holdings …
ROE (TTM)Return on equity+20.1%+9.7%+19.6%+21.1%
ROA (TTM)Return on assets+8.1%+5.6%+5.7%+4.2%
ROICReturn on invested capital+14.8%+21.9%+13.2%+1.9%
ROCEReturn on capital employed+13.2%+16.8%+13.8%+2.5%
Piotroski ScoreFundamental quality 0–97774
Debt / EquityFinancial leverage0.76x0.00x1.47x1.32x
Net DebtTotal debt minus cash$285M-$61M$10.3B$3.9B
Cash & Equiv.Liquid assets$375M$62M$2.9B$4M
Total DebtShort + long-term debt$660M$491,000$13.2B$3.9B
Interest CoverageEBIT ÷ Interest expense20.20x4.28x5.98x
AMSF leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

THC leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in THC five years ago would be worth $29,044 today (with dividends reinvested), compared to $7,143 for MD. Over the past 12 months, MD leads with a +59.8% total return vs AMSF's -29.2%. The 3-year compound annual growth rate (CAGR) favors THC at 40.7% vs AMSF's -9.1% — a key indicator of consistent wealth creation.

MetricMD logoMDPediatrix Medical…AMSF logoAMSFAMERISAFE, Inc.THC logoTHCTenet Healthcare …KNTK logoKNTKKinetik Holdings …
YTD ReturnYear-to-date+7.7%-18.3%-2.7%+37.4%
1-Year ReturnPast 12 months+59.8%-29.2%+27.4%+28.0%
3-Year ReturnCumulative with dividends+67.0%-24.8%+178.5%+93.9%
5-Year ReturnCumulative with dividends-28.6%-18.9%+190.4%+93.1%
10-Year ReturnCumulative with dividends-67.1%+31.8%+523.4%-33.5%
CAGR (3Y)Annualised 3-year return+18.6%-9.1%+40.7%+24.7%
THC leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — AMSF and KNTK each lead in 1 of 2 comparable metrics.

AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than MD's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KNTK currently trades 94.8% from its 52-week high vs AMSF's 62.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMD logoMDPediatrix Medical…AMSF logoAMSFAMERISAFE, Inc.THC logoTHCTenet Healthcare …KNTK logoKNTKKinetik Holdings …
Beta (5Y)Sensitivity to S&P 5000.73x0.23x0.71x0.60x
52-Week HighHighest price in past year$24.99$48.54$247.21$51.11
52-Week LowLowest price in past year$11.84$29.42$146.60$31.33
% of 52W HighCurrent price vs 52-week peak+91.8%+62.4%+78.5%+94.8%
RSI (14)Momentum oscillator 0–10051.334.252.951.3
Avg Volume (50D)Average daily shares traded772K212K1.2M1.2M
Evenly matched — AMSF and KNTK each lead in 1 of 2 comparable metrics.

Analyst Outlook

KNTK leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: MD as "Hold", AMSF as "Buy", THC as "Buy", KNTK as "Buy". Consensus price targets imply 46.9% upside for AMSF (target: $45) vs -3.0% for MD (target: $22). For income investors, KNTK offers the higher dividend yield at 16.47% vs AMSF's 8.41%.

MetricMD logoMDPediatrix Medical…AMSF logoAMSFAMERISAFE, Inc.THC logoTHCTenet Healthcare …KNTK logoKNTKKinetik Holdings …
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$22.25$44.50$268.00$47.57
# AnalystsCovering analysts3363215
Dividend YieldAnnual dividend ÷ price+8.4%+16.5%
Dividend StreakConsecutive years of raises003
Dividend / ShareAnnual DPS$2.55$7.98
Buyback YieldShare repurchases ÷ mkt cap+4.6%+2.1%+8.4%+5.3%
KNTK leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

AMSF leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). THC leads in 2 (Valuation Metrics, Total Returns). 1 tied.

Best OverallAMERISAFE, Inc. (AMSF)Leads 2 of 6 categories
Loading custom metrics...

MD vs AMSF vs THC vs KNTK: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is MD or AMSF or THC or KNTK a better buy right now?

For growth investors, Kinetik Holdings Inc.

(KNTK) is the stronger pick with 19. 0% revenue growth year-over-year, versus -4. 9% for Pediatrix Medical Group, Inc. (MD). Pediatrix Medical Group, Inc. (MD) offers the better valuation at 11. 8x trailing P/E (10. 3x forward), making it the more compelling value choice. Analysts rate AMERISAFE, Inc. (AMSF) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MD or AMSF or THC or KNTK?

On trailing P/E, Pediatrix Medical Group, Inc.

(MD) is the cheapest at 11. 8x versus Kinetik Holdings Inc. at 18. 4x. On forward P/E, Pediatrix Medical Group, Inc. is actually cheaper at 10. 3x.

03

Which is the better long-term investment — MD or AMSF or THC or KNTK?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +190.

4%, compared to -28. 6% for Pediatrix Medical Group, Inc. (MD). Over 10 years, the gap is even starker: THC returned +523. 4% versus MD's -67. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MD or AMSF or THC or KNTK?

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus Pediatrix Medical Group, Inc. 's 0. 73β — meaning MD is approximately 214% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 147% for Tenet Healthcare Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — MD or AMSF or THC or KNTK?

By revenue growth (latest reported year), Kinetik Holdings Inc.

(KNTK) is pulling ahead at 19. 0% versus -4. 9% for Pediatrix Medical Group, Inc. (MD). On earnings-per-share growth, the picture is similar: Pediatrix Medical Group, Inc. grew EPS 263. 0% year-over-year, compared to -52. 6% for Tenet Healthcare Corporation. Over a 3-year CAGR, KNTK leads at 13. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MD or AMSF or THC or KNTK?

AMERISAFE, Inc.

(AMSF) is the more profitable company, earning 14. 9% net margin versus 6. 6% for Tenet Healthcare Corporation — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 9. 3% for KNTK. At the gross margin level — before operating expenses — THC leads at 82. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MD or AMSF or THC or KNTK more undervalued right now?

On forward earnings alone, Pediatrix Medical Group, Inc.

(MD) trades at 10. 3x forward P/E versus 42. 4x for Kinetik Holdings Inc. — 32. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMSF: 46. 9% to $44. 50.

08

Which pays a better dividend — MD or AMSF or THC or KNTK?

In this comparison, KNTK (16.

5% yield), AMSF (8. 4% yield) pay a dividend. MD, THC do not pay a meaningful dividend and should not be held primarily for income.

09

Is MD or AMSF or THC or KNTK better for a retirement portfolio?

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Both have compounded well over 10 years (AMSF: +31. 8%, MD: -67. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MD and AMSF and THC and KNTK?

These companies operate in different sectors (MD (Healthcare) and AMSF (Financial Services) and THC (Healthcare) and KNTK (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MD is a small-cap deep-value stock; AMSF is a small-cap deep-value stock; THC is a mid-cap deep-value stock; KNTK is a small-cap high-growth stock. AMSF, KNTK pay a dividend while MD, THC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

MD

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

AMSF

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

KNTK

Income & Dividend Stock

  • Sector: Energy
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 6.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MD and AMSF and THC and KNTK on the metrics below

Revenue Growth>
%
(MD: 3.9% · AMSF: 10.3%)
Net Margin>
%
(MD: 9.0% · AMSF: 14.3%)
P/E Ratio<
x
(MD: 11.8x · AMSF: 12.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.